Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat vs allopurinol in gout with hyperuricemia (CTR20132296)
CTR20132296Phase 2Active
- Sponsor
- Tianjin Hankang Pharmaceutical Biotechnology
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of febuxostat in gout, hyperuricemia, sponsored by Tianjin Hankang Pharmaceutical Biotechnology. Started Dec 2014; status: active.
02
Drugs
febuxostat
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on CTR20132296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132296.